Acadia Healthcare - ACHC Stock Forecast, Price & News

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Acadia Healthcare in the last twelve months. There are currently 1 hold rating and 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" ACHC shares.
View ACHC analyst ratings or view top-rated stocks.

4 brokerages have issued 12-month target prices for Acadia Healthcare's stock. Their ACHC share price forecasts range from $69.00 to $103.00. On average, they anticipate the company's stock price to reach $83.88 in the next year. This suggests that the stock has a possible downside of 0.0%.
View analysts price targets for ACHC or view top-rated stocks among Wall Street analysts.

Acadia Healthcare's stock was trading at $60.70 at the start of the year. Since then, ACHC stock has increased by 38.2% and is now trading at $83.88.
View the best growth stocks for 2022 here.

The company is scheduled to release its next quarterly earnings announcement on Thursday, October 27th 2022.
View our ACHC earnings forecast.

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) issued its quarterly earnings data on Wednesday, July, 27th. The company reported $0.84 earnings per share for the quarter, beating the consensus estimate of $0.77 by $0.07. The company had revenue of $651.72 million for the quarter, compared to analyst estimates of $650.80 million. Acadia Healthcare had a trailing twelve-month return on equity of 10.34% and a net margin of 11.32%. The business's quarterly revenue was up 11.9% compared to the same quarter last year. During the same period last year, the business posted $0.71 EPS.

Acadia Healthcare issued an update on its FY 2022 earnings guidance on Thursday, August, 4th. The company provided EPS guidance of $2.93-$3.18 for the period, compared to the consensus estimate of $3.01. The company issued revenue guidance of $2.56 billion-$2.60 billion, compared to the consensus revenue estimate of $2.59 billion.

41 employees have rated Acadia Healthcare Chief Executive Officer Debra K. Osteen on Glassdoor.com. Debra K. Osteen has an approval rating of 36% among the company's employees. This puts Debra K. Osteen in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Acadia Healthcare investors own include Chipotle Mexican Grill (CMG), Endologix (ELGX), American Airlines Group (AAL), Archer-Daniels-Midland (ADM), APA (APA), Athabasca Oil (ATH), Aegean Marine Petroleum Network (ANW), Broadcom (AVGO), Exxon Mobil (XOM) and Colfax (CFX).

Acadia Healthcare trades on the NASDAQ under the ticker symbol "ACHC."

Shares of ACHC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of ACHC stock can currently be purchased for approximately $83.88.

Acadia Healthcare (NASDAQ:ACHC) has a market capitalization of $7.62 billion and generates $2.31 billion in revenue each year. The company earns $190.63 million in net income (profit) each year or $3.05 on an earnings per share basis.

The company employs 22,500 workers across the globe.

Acadia Healthcare's mailing address is 6100 TOWER CIRCLE SUITE 1000, FRANKLIN TN, 37067. The official website for the company is www.acadiahealthcare.com. The company can be reached via phone at (615) 861-6000 or via fax at 615-261-9685.